Quote of the Month – Thomas J. Fuchs
Artificial intelligence will put pathologists front and center in patient care decisions
The recent FDA approval of the first artificial intelligence (AI) in pathology showed that, after decades of research, we have finally entered a new phase of pathology in which AI-driven tools are used in clinical practice for patient care on a daily basis.
In the near future, pathology is going to be one of the most exciting fields in healthcare. It is important to understand that we are just barely scratching the surface of what could be learned from tissue morphology in H&E slides. AI generates a wealth of insight from each patient sample that pathologists can have at their fingertips – ranging from complete, quantitative morphological workups to exciting novel computational biomarkers. This will supercharge the role of the pathologist and elevate diagnostic professionals to the center of decision-making for patient treatment.
The Barbara T. Murphy Professor at the Icahn School of Medicine at Mount Sinai, Chair of the Windreich Department of Artificial Intelligence and Human Health, Co-Director of the Hasso Plattner Institute for Digital Health, and Founder and Chief Scientist of Paige.AI.
